{"content":"<li class=\"n-box-item date-title\" data-end=\"1364011199\" data-start=\"1363924800\" data-txt=\"Friday, December 20, 2019\">Friday, March 22, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"906011\" data-ts=\"1363989692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDIX\" target=\"_blank\">IDIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/906011\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Idenix Pharmaceuticals (NASDAQ:IDIX) says the USPTO&#39;s Patent Trial and Appeal Board has decided...</a></h4><p>Idenix Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/IDIX\" title=\"Idenix Pharmaceuticals, Inc.\">IDIX</a>) says the USPTO's Patent Trial and Appeal Board has decided against it in the first phase of its two-stage interference process concerning one of <a href=\"https://seekingalpha.com/symbol/IDIX\" title=\"Idenix Pharmaceuticals, Inc.\">IDIX</a>'s patent applications, and an issued patent owned by Gilead Pharmasset (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a>) that covers certain 2'-methyl- 2'-fluoro nucleoside compounds useful in the treatment of the hepatitis C virus. Shares <font color=\"red\">-13%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"906011\" data-linked=\"Idenix Pharmaceuticals (NASDAQ:IDIX) says the USPTO&#39;s Patent Trial and Appeal Board has decided...\" data-tweet=\"$IDIX $IDIX $GILD - Idenix Pharmaceuticals (NASDAQ:IDIX) says the USPTO&#39;s Patent Trial and Appeal Board has decided against it in the first phase of its two-stage interference process concerning one of IDIX&#39;s patent applications, and an issued patent ow... https://seekingalpha.com/news/906011?source=tweet\" data-url=\"https://seekingalpha.com/news/906011\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"906021\" data-ts=\"1363988662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFD\" target=\"_blank\">SFD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/906021\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers, as of 5:15 p.m.: SFD +6%. REGI +6%. GTI +4%. FIVE +4%. KWK +4%....</a></h4><b>After-hours top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/SFD' title='Smithfield Foods Inc.'>SFD</a> <font color=\"green\">+6%</font>. <a href='https://seekingalpha.com/symbol/REGI' title='Renewable Energy Group, Inc'>REGI</a> <font color=\"green\">+6%</font>. GTI <font color=\"green\">+4%</font>. <a href='https://seekingalpha.com/symbol/FIVE' title='Five Below'>FIVE</a> <font color=\"green\">+4%</font>. <a href='https://seekingalpha.com/symbol/KWK' title='Quicksilver Resources Inc.'>KWK</a> <font color=\"green\">+4%</font>. <br /><b>After-hours top losers:</b> <a href='https://seekingalpha.com/symbol/IDIX' title='Idenix Pharmaceuticals, Inc.'>IDIX</a> <font color=\"red\">-10%</font>. <a href='https://seekingalpha.com/symbol/TTS' title='Tile Shop Holdings, Inc.'>TTS</a> <font color=\"red\">-6%</font>. <a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a> <font color=\"red\">-4%</font>. <a href='https://seekingalpha.com/symbol/MTG' title='MGIC Investment Corporation'>MTG</a> <font color=\"red\">-3%</font>. <a href='https://seekingalpha.com/symbol/ARNA' title='Arena Pharmaceuticals, Inc.'>ARNA</a> <font color=\"red\">-2%</font>.<div class=\"tiny-share-widget\" data-id=\"906021\" data-linked=\"After-hours top gainers, as of 5:15 p.m.: SFD +6%. REGI +6%. GTI +4%. FIVE +4%. KWK +4%....\" data-tweet=\"$SFD $SFD $REGI - After-hours top gainers, as of 5:15 p.m.: SFD +6%. REGI +6%. GTI +4%. FIVE +4%. KWK +4%. After-hours top losers: IDIX -10%. TTS -6%. SVU -4%. MTG -3%. ARNA -2%. https://seekingalpha.com/news/906021?source=tweet\" data-url=\"https://seekingalpha.com/news/906021\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905951\" data-ts=\"1363986682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFD\" target=\"_blank\">SFD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905951\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smithfield Foods (NYSE:SFD) has hired Goldman Sachs to explore its options, after Continental...</a></h4><p>Smithfield Foods (NYSE:<a href=\"https://seekingalpha.com/symbol/SFD\" title=\"Smithfield Foods Inc.\">SFD</a>) has <a href=\"http://www.reuters.com/article/2013/03/22/smithfield-goldmansachs-idUSL1N0CAD6420130322?type=companyNews\" target=\"_blank\">hired Goldman Sachs</a> to explore its options, after Continental Grain, an agribusiness company which controls about 6% of the company, <a href=\"https://seekingalpha.com/market_currents/post/877401\" target=\"_blank\">urged the hog producer</a> to break up. Goldman will assist in analyzing and reviewing strategic options including instituting a cash dividend, bringing on new board members and executives with new skills, or potentially even splitting into three companies. Shares <font color=\"green\">+3%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"905951\" data-linked=\"Smithfield Foods (NYSE:SFD) has hired Goldman Sachs to explore its options, after Continental...\" data-tweet=\"$SFD - Smithfield Foods (NYSE:SFD) has hired Goldman Sachs to explore its options, after Continental Grain, an agribusiness company which controls about 6% of the company, urged the hog producer to break up. Goldman will assist in analyzing and reviewin... https://seekingalpha.com/news/905951?source=tweet\" data-url=\"https://seekingalpha.com/news/905951\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905821\" data-ts=\"1363984363\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905821\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The week&#39;s ETF movers - Gainers: AMJ +3.37%. VXX +2.24%. GDX +2.20%. XLP +2.13%. UNG +1.98%. ETF...</a></h4><b>The week's ETF movers - Gainers:</b> <a href='https://seekingalpha.com/symbol/amj' title='JPMorgan Alerian MLP Index ETN'>AMJ</a> <font color=\"green\">+3.37%</font>. <a href='https://seekingalpha.com/symbol/vxx' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color=\"green\">+2.24%</font>. <a href='https://seekingalpha.com/symbol/gdx' title='Market Vectors Gold Miners ETF'>GDX</a> <font color=\"green\">+2.20%</font>. <a href='https://seekingalpha.com/symbol/xlp' title='Consumer Staples Select Sector SPDR ETF'>XLP</a> <font color=\"green\">+2.13%</font>. <a href='https://seekingalpha.com/symbol/ung' title='The United States Natural Gas ETF, LP'>UNG</a> <font color=\"green\">+1.98%</font>.  <br /><b>ETF Losers:</b> <a href='https://seekingalpha.com/symbol/epi' title='WisdomTree India Earnings ETF'>EPI</a> <font color=\"red\">-5.54%</font>. <a href='https://seekingalpha.com/symbol/brf' title='Market Vectors Brazil Small-Cap ETF'>BRF</a> <font color=\"red\">-4.26%</font>. <a href='https://seekingalpha.com/symbol/kol' title='Market Vectors Coal ETF'>KOL</a> <font color=\"red\">-3.67%</font>. <a href='https://seekingalpha.com/symbol/ewz' title='iShares MSCI Brazil Index ETF'>EWZ</a> <font color=\"red\">-3.64%</font>. <a href='https://seekingalpha.com/symbol/fcg' title='First Trust ISE-Revere Natural Gas Index ETF'>FCG</a> <font color=\"red\">-3.43%</font>.<div class=\"tiny-share-widget\" data-id=\"905821\" data-linked=\"The week&#39;s ETF movers - Gainers: AMJ +3.37%. VXX +2.24%. GDX +2.20%. XLP +2.13%. UNG +1.98%. ETF...\" data-tweet=\"$AMJ $VXX $GDX - The week&#39;s ETF movers - Gainers: AMJ +3.37%. VXX +2.24%. GDX +2.20%. XLP +2.13%. UNG +1.98%. ETF Losers: EPI -5.54%. BRF -4.26%. KOL -3.67%. EWZ -3.64%. FCG -3.43%. https://seekingalpha.com/news/905821?source=tweet\" data-url=\"https://seekingalpha.com/news/905821\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905771\" data-ts=\"1363983034\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905771\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Isis Pharmaceuticals (ISIS -6.1%) becomes a casualty of the European Medicines Agency today, as...</a></h4><p>Isis Pharmaceuticals (ISIS <font color=\"red\">-6.1%</font>) becomes a casualty of the European Medicines Agency today, as the committee confirmed its previous position and maintained a negative opinion on the marketing authorization application for Kynamro as a treatment for patients with Homozygous Familial Hypercholesterolaemia.</p><div class=\"tiny-share-widget\" data-id=\"905771\" data-linked=\"Isis Pharmaceuticals (ISIS -6.1%) becomes a casualty of the European Medicines Agency today, as...\" data-tweet=\"$IONS - Isis Pharmaceuticals (ISIS -6.1%) becomes a casualty of the European Medicines Agency today, as the committee confirmed its previous position and maintained a negative opinion on the marketing authorization application for Kynamro as a treatment... https://seekingalpha.com/news/905771?source=tweet\" data-url=\"https://seekingalpha.com/news/905771\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905701\" data-ts=\"1363981024\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTX\" target=\"_blank\">CYTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905701\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cytori Therapeutics (CYTX -2.2%) retreats in afternoon trading after a U.S. Appeals court upheld...</a></h4><p>Cytori Therapeutics (<a href=\"https://seekingalpha.com/symbol/CYTX\" title=\"Cytori Therapeutics Inc\">CYTX</a> <font color=\"red\">-2.2%</font>) retreats in afternoon trading after a U.S. Appeals court upheld an FDA decision not to approve two stem-cell therapy devices. The court agreed with the FDA, noting that the devices weren't \"substantially equivalent to the cited predicate devices.\" <a href=\"https://seekingalpha.com/symbol/CYTX\" title=\"Cytori Therapeutics Inc\">CYTX</a> says it plans to continue to seek approval for the therapy through the <a target=\"_blank\" href=\"http://www.emergogroup.com/services/us/fda-premarket-approval?gclid=CPO40KmIkbYCFad_Qgod6E0AhQ\">Premarket Approval</a> route, which is far more complex and time-consuming than the traditional 510(k) premarket process.</p><div class=\"tiny-share-widget\" data-id=\"905701\" data-linked=\"Cytori Therapeutics (CYTX -2.2%) retreats in afternoon trading after a U.S. Appeals court upheld...\" data-tweet=\"$CYTX $PSTV - Cytori Therapeutics (CYTX -2.2%) retreats in afternoon trading after a U.S. Appeals court upheld an FDA decision not to approve two stem-cell therapy devices. The court agreed with the FDA, noting that the devices weren&#39;t &quot;substantially eq... https://seekingalpha.com/news/905701?source=tweet\" data-url=\"https://seekingalpha.com/news/905701\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905651\" data-ts=\"1363979727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KKR\" target=\"_blank\">KKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905651\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KKR (KKR -2%) and TPG Capital are apparently no longer planning to bid for Life Technologies...</a></h4><p>KKR (<a href=\"https://seekingalpha.com/symbol/KKR\" title=\"KKR\">KKR</a> <font color=\"red\">-2%</font>) and TPG Capital are apparently <a target=\"_blank\" href=\"http://www.bloomberg.com/news/2013-03-22/life-sale-said-to-shift-to-strategics-as-buyout-firms-go.html\">no longer planning to bid</a> for Life Technologies (<a href=\"https://seekingalpha.com/symbol/LIFE\" title=\"aTyr Pharma\">LIFE</a> <font color=\"red\">-0.1%</font>). According to reports, the company is more likely to be sold to a corporate buyer, possibly  Danaher (<a href=\"https://seekingalpha.com/symbol/DHR\" title=\"Danaher Corporation\">DHR</a> <font color=\"green\">+0.6%</font>) or Thermo Fisher Scientific (<a href=\"https://seekingalpha.com/symbol/TMO\" title=\"Thermo Fisher Scientific Inc.\">TMO</a> <font color=\"red\">-0.9%</font>). <a href=\"https://seekingalpha.com/symbol/LIFE\" title=\"aTyr Pharma\">LIFE</a> had initially sought a private equity firm to acquire the company in a leveraged buyout, but strategic bidders emerged who may be in better position because opportunities to cut costs mean they could make a higher offer.</p><div class=\"tiny-share-widget\" data-id=\"905651\" data-linked=\"KKR (KKR -2%) and TPG Capital are apparently no longer planning to bid for Life Technologies...\" data-tweet=\"$KKR $KKR $TMO - KKR (KKR -2%) and TPG Capital are apparently no longer planning to bid for Life Technologies (LIFE -0.1%). According to reports, the company is more likely to be sold to a corporate buyer, possibly Danaher (DHR +0.6%) or Thermo Fisher S... https://seekingalpha.com/news/905651?source=tweet\" data-url=\"https://seekingalpha.com/news/905651\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905631\" data-ts=\"1363979408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSN\" target=\"_blank\">SSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905631\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Samson Oil &amp;amp;&amp;nbsp;Gas (SSN -15.6%) hits a 52-week low after last night&#39;s news it raised...</a></h4><p>Samson Oil &amp; Gas (<a href=\"https://seekingalpha.com/symbol/SSN\" title=\"Samson Oil &amp; Gas Limited\">SSN</a> <font color=\"red\">-15.6%</font>) hits a 52-week low after last night's news it raised $2.8M from U.S. institutional investors through a placement of American Depositary shares and a shareholder rights offering; SSN plans to use the proceeds to drill six development wells in North Dakota.</p><div class=\"tiny-share-widget\" data-id=\"905631\" data-linked=\"Samson Oil &amp;amp; Gas (SSN -15.6%) hits a 52-week low after last night&#39;s news it raised $2.8M...\" data-tweet=\"$SSN - Samson Oil &amp; Gas (SSN -15.6%) hits a 52-week low after last night&#39;s news it raised $2.8M from U.S. institutional investors through a placement of American Depositary shares and a shareholder rights offering; SSN plans to use the proceeds to drill... https://seekingalpha.com/news/905631?source=tweet\" data-url=\"https://seekingalpha.com/news/905631\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905611\" data-ts=\"1363978538\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905611\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry (BBRY -6.9%) plummets as the WSJ reports AT&amp;amp;T (NYSE:T) &quot;doesn&#39;t appear to be...</a></h4><p>BlackBerry (BBRY <font color=\"red\">-6.9%</font>) plummets as <a href=\"http://online.wsj.com/article_email/SB10001424127887324557804578376483088841400-lMyQjAxMTAzMDIwMjEyNDIyWj.html\" target=\"_blank\">the <em>WSJ</em> reports</a> AT&amp;T (NYSE:<a href=\"https://seekingalpha.com/symbol/T\" title=\"AT&amp;T Inc.\">T</a>) \"doesn't appear to be highlighting\" the Z10 on its launch day, or \"giving it prominent shelf space at its stores.\" The paper observes \"fewer than 20 people\" arrived at two Manhattan AT&amp;T stores to see the Z10, and that a San Francisco store chose to display it \"at a back corner of the store, away from a large sign advertising the iPhone 5.\" (<a href=\"https://seekingalpha.com/currents/post/905151\" target=\"_blank\">earlier</a>)</p><div class=\"tiny-share-widget\" data-id=\"905611\" data-linked=\"BlackBerry (BBRY -6.9%) plummets as the WSJ reports AT&amp;amp;T (NYSE:T) &quot;doesn&#39;t appear to be...\" data-tweet=\"$BB $BB $T - BlackBerry (BBRY -6.9%) plummets as the WSJ reports AT&amp;T (NYSE:T) &quot;doesn&#39;t appear to be highlighting&quot; the Z10 on its launch day, or &quot;giving it prominent shelf space at its stores.&quot; The paper observes &quot;fewer than 20 people&quot; arrived at two Ma... https://seekingalpha.com/news/905611?source=tweet\" data-url=\"https://seekingalpha.com/news/905611\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905591\" data-ts=\"1363978311\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNY\" target=\"_blank\">SNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905591\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sanofi&#39;s (SNY +1.4%) Genzyme says that the European Medicines Agency has issued a positive...</a></h4><p>Sanofi's (<a href=\"https://seekingalpha.com/symbol/SNY\" title=\"Sanofi\">SNY</a> <font color=\"green\">+1.4%</font>) Genzyme says that the European Medicines Agency has issued a positive opinion for the approval of Aubagio, which is a treatment of relapsing-remitting multiple sclerosis. It did not howvever, recommend the drug receive a new active substance designation, which <a href=\"https://seekingalpha.com/symbol/SNY\" title=\"Sanofi\">SNY</a> believes could have a detrimental impact on future research on MS, as well as other diseases. The drug developer is now planning to request a re-examination of the decision.</p><div class=\"tiny-share-widget\" data-id=\"905591\" data-linked=\"Sanofi&#39;s (SNY +1.4%) Genzyme says that the European Medicines Agency has issued a positive...\" data-tweet=\"$SNY - Sanofi&#39;s (SNY +1.4%) Genzyme says that the European Medicines Agency has issued a positive opinion for the approval of Aubagio, which is a treatment of relapsing-remitting multiple sclerosis. It did not howvever, recommend the drug receive a new ... https://seekingalpha.com/news/905591?source=tweet\" data-url=\"https://seekingalpha.com/news/905591\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905561\" data-ts=\"1363977641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILD\" target=\"_blank\">GILD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905561\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The hits keep coming out of Europe for healthcare stocks today, as Gilead Sciences (GILD +2%)...</a></h4><p>The hits keep coming out of Europe for <a href=\"https://seekingalpha.com/market_currents/post/905521\" target=\"_blank\">healthcare stocks</a> today, as Gilead Sciences (<a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a> <font color=\"green\">+2%</font>) moves up after the Europan Union's CHMP earlier today adopted a positive opinion on the company's Marketing Authorization for Stribild, a treatment for HIV-1 infection in patients who are antiretroviral-naive or are infected with HIV-1 without known mutations associated with resistance to any of the three antiretroviral agents in Stribild: elvitegravir, an integrase inhibitor, or cobicistat.</p><div class=\"tiny-share-widget\" data-id=\"905561\" data-linked=\"The hits keep coming out of Europe for healthcare stocks today, as Gilead Sciences (GILD +2%)...\" data-tweet=\"$GILD - The hits keep coming out of Europe for healthcare stocks today, as Gilead Sciences (GILD +2%) moves up after the Europan Union&#39;s CHMP earlier today adopted a positive opinion on the company&#39;s Marketing Authorization for Stribild, a treatment for... https://seekingalpha.com/news/905561?source=tweet\" data-url=\"https://seekingalpha.com/news/905561\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905551\" data-ts=\"1363977508\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ODFL\" target=\"_blank\">ODFL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905551\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Old Dominion Freight (ODFL +5.5%) shares are strong after the less-than-truckload motor carrier...</a></h4><p>Old Dominion Freight (<a href=\"https://seekingalpha.com/symbol/ODFL\" title=\"Old Dominion Freight Line, Inc.\">ODFL</a> <font color=\"green\">+5.5%</font>) shares are strong after the less-than-truckload motor carrier last night raised expectations for Q1 tonnage growth to 4.5%-5% from a previous 4%-4.5% and affirmed expectations for a Y/Y increase in revenue per hundredweight excluding a fuel surcharge in range of 2.5%-3%. Goldman Sachs reiterates its <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/03/3440074/goldman-sachs-reiterates-conviction-list-buy-on-old-domi\" target=\"_blank\">Conviction Buy rating</a>.</p><div class=\"tiny-share-widget\" data-id=\"905551\" data-linked=\"Old Dominion Freight (ODFL +5.5%) shares are strong after the less-than-truckload motor carrier...\" data-tweet=\"$ODFL - Old Dominion Freight (ODFL +5.5%) shares are strong after the less-than-truckload motor carrier last night raised expectations for Q1 tonnage growth to 4.5%-5% from a previous 4%-4.5% and affirmed expectations for a Y/Y increase in revenue per h... https://seekingalpha.com/news/905551?source=tweet\" data-url=\"https://seekingalpha.com/news/905551\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905521\" data-ts=\"1363976927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905521\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen Idec (BIIB +1.2%) is another beneficiary of a positive opinion from the EU&#39;s Committee...</a></h4><p>Biogen Idec (<a href=\"https://seekingalpha.com/symbol/BIIB\" title=\"Biogen Inc.\">BIIB</a> <font color=\"green\">+1.2%</font>) is another beneficiary of a <a href=\"https://seekingalpha.com/market_currents/post/904671\" target=\"_blank\">positive opinion</a> from the EU's Committee for Medicinal Products for Human Use, recommending that the company's Techfidera be <a href=\"http://www.streetinsider.com/Corporate+News/Biogen+Idec+%28BIIB%29+TECFIDERA+Receives+Positive+EMA+CHMP+Opinion/8205718.html\" target=\"_blank\">granted marketing authorization</a> as a first-line oral treatment for adults with relapsing-remitting multiple sclerosis. <a href=\"https://seekingalpha.com/symbol/BIIB\" title=\"Biogen Inc.\">BIIB</a> notes the FDA is also expected to make a decision on its marketing application for the drug in the U.S. in the coming days.</p><div class=\"tiny-share-widget\" data-id=\"905521\" data-linked=\"Biogen Idec (BIIB +1.2%) is another beneficiary of a positive opinion from the EU&#39;s Committee...\" data-tweet=\"$BIIB - Biogen Idec (BIIB +1.2%) is another beneficiary of a positive opinion from the EU&#39;s Committee for Medicinal Products for Human Use, recommending that the company&#39;s Techfidera be granted marketing authorization as a first-line oral treatment for ... https://seekingalpha.com/news/905521?source=tweet\" data-url=\"https://seekingalpha.com/news/905521\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905501\" data-ts=\"1363976823\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BP\" target=\"_blank\">BP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905501\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts at Simmons say the scale of BP&#39;s (BP +2.4%) $8B buyback, at more than 6% of BP&amp;rsquo;s...</a></h4><p>Analysts at Simmons say the scale of BP's (<a href=\"https://seekingalpha.com/symbol/BP\" title=\"BP p.l.c.\">BP</a> <font color=\"green\">+2.4%</font>) <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/903901\">$8B buyback</a>, at more than 6% of BP\u2019s market value, is <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/03/22/tiffany-nike-bp-shares-rally/\" target=\"_blank\">larger than it had expected</a> by ~$1B. But <a target=\"_blank\" href=\"http://www.ft.com/intl/cms/s/9bfb66de-92fc-11e2-9593-00144feabdc0,Authorised=false.html?_i_location=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F3%2F9bfb66de-92fc-11e2-9593-00144feabdc0.html&amp;_i_referer=http%3A%2F%2Ft.co%2FKxDuGjeTbr#axzz2OHtlu15H\">not everyone thinks it's money well spent</a>: $8B spread over BP\u2019s outstanding shares could pay a one-time dividend of ~$2.50/share, and there's little doubt what most shareholders would choose if they could.</p><div class=\"tiny-share-widget\" data-id=\"905501\" data-linked=\"Analysts at Simmons say the scale of BP&#39;s (BP +2.4%) $8B buyback, at more than 6% of BP\u2019s market...\" data-tweet=\"$BP - Analysts at Simmons say the scale of BP&#39;s (BP +2.4%) $8B buyback, at more than 6% of BP\u2019s market value, is larger than it had expected by ~$1B. But not everyone thinks it&#39;s money well spent: $8B spread over BP\u2019s outstanding shares could pay a one-... https://seekingalpha.com/news/905501?source=tweet\" data-url=\"https://seekingalpha.com/news/905501\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905441\" data-ts=\"1363974803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRUS\" target=\"_blank\">CRUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905441\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC&#39;s report about a cheaper iPhone arriving in the June/July timeframe appears to be giving a...</a></h4><a href=\"https://seekingalpha.com/currents/post/905261\" target=\"_blank\">RBC's report</a> about a cheaper iPhone arriving in the June/July timeframe appears to be giving a lift to Cirrus Logic (<a href=\"https://seekingalpha.com/symbol/CRUS\" title=\"Cirrus Logic, Inc.\">CRUS</a> <font color=\"green\">+3.2%</font>). A <a href=\"http://appleinsider.com/articles/13/03/22/rumor-apple-to-launch-cheaper-iphone-with-plastic-casing-non-retina-display-this-summer\" target=\"_blank\">prediction</a> the device will yield $22B in 2014 sales on the back of 72M shipments probably isn't hurting either. Whereas many on the Street are ambivalent about the impact of a less costly iPhone on Apple - positive on its sales/market share effect, but concerned about cannibalization and margin pressure - its arrival would be a clear-cut positive for Cirrus, provided it lands the phone's audio codec slot.<div class=\"tiny-share-widget\" data-id=\"905441\" data-linked=\"RBC&#39;s report about a cheaper iPhone arriving in the June/July timeframe appears to be giving a...\" data-tweet=\"$CRUS - RBC&#39;s report about a cheaper iPhone arriving in the June/July timeframe appears to be giving a lift to Cirrus Logic (CRUS +3.2%). A prediction the device will yield $22B in 2014 sales on the back of 72M shipments probably isn&#39;t hurting either. W... https://seekingalpha.com/news/905441?source=tweet\" data-url=\"https://seekingalpha.com/news/905441\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905431\" data-ts=\"1363973934\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUM\" target=\"_blank\">HUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905431\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Humana (HUM -2.9%) trades lower today after Susquehanna cut the shares to Neutral and lowered...</a></h4><p>Humana (<a href=\"https://seekingalpha.com/symbol/HUM\" title=\"Humana Inc.\">HUM</a> <font color=\"red\">-2.9%</font>) trades lower today after Susquehanna <a href=\"http://www.streetinsider.com/Downgrades/Susquehanna+Downgrades+Humana+%28HUM%29+to+Neutral/8205574.html\" target=\"_blank\">cut the shares</a> to Neutral and lowered its target price to $74 from $85. The firm says it's opting to stay away from the potential volatility, believing the shares could swing wildly between the high-$40s to the mid-$80s depending on how the final 2014 Medicare Advantage rates - due to be released April 1 - play out.</p><div class=\"tiny-share-widget\" data-id=\"905431\" data-linked=\"Humana (HUM -2.9%) trades lower today after Susquehanna cut the shares to Neutral and lowered...\" data-tweet=\"$HUM - Humana (HUM -2.9%) trades lower today after Susquehanna cut the shares to Neutral and lowered its target price to $74 from $85. The firm says it&#39;s opting to stay away from the potential volatility, believing the shares could swing wildly between ... https://seekingalpha.com/news/905431?source=tweet\" data-url=\"https://seekingalpha.com/news/905431\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905411\" data-ts=\"1363973060\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WSTC\" target=\"_blank\">WSTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905411\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Unlike Marin Software, West Corp. (NASDAQ:WSTC) is having an unpleasant opening day. After...</a></h4><p>Unlike <a href=\"https://seekingalpha.com/currents/post/904901\" target=\"_blank\">Marin Software</a>, West Corp. (NASDAQ:<a href=\"https://seekingalpha.com/symbol/WSTC\" title=\"West Corporation\">WSTC</a>) is having an unpleasant opening day. After pricing its 21.3M-share IPO at $20 (below a range of $22-$25), shares opened at $19.04 and are currently at $19.15, <font color=\"red\">down 4.3%</font>. That's good for a market cap of $1.6B. The provider of conferencing and contact center outsourcing services posted 2012 revenue of $2.64B (+6% Y/Y) and net income of $125.5M (-2%). It competes with IT and telecom giants offering hosted services, as well as smaller firms such as ShorteTel (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SHOR\" title=\"ShoreTel, Inc.\">SHOR</a>) and 8x8 (NASDAQ:<a href=\"https://seekingalpha.com/symbol/EGHT\" title=\"8X8 Inc\">EGHT</a>). (<a href=\"http://www.sec.gov/Archives/edgar/data/1024657/000119312513108521/d477270ds1a.htm\" target=\"_blank\">S-1</a>)</p><div class=\"tiny-share-widget\" data-id=\"905411\" data-linked=\"Unlike Marin Software, West Corp. (NASDAQ:WSTC) is having an unpleasant opening day. After...\" data-tweet=\"$WSTC $WSTC $SHOR - Unlike Marin Software, West Corp. (NASDAQ:WSTC) is having an unpleasant opening day. After pricing its 21.3M-share IPO at $20 (below a range of $22-$25), shares opened at $19.04 and are currently at $19.15, down 4.3%. That&#39;s good for... https://seekingalpha.com/news/905411?source=tweet\" data-url=\"https://seekingalpha.com/news/905411\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905391\" data-ts=\"1363971955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLY\" target=\"_blank\">NLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905391\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The mREITs are back in favor after the Fed&#39;s QE&amp;infin; hit interest margins in Q4. A widening...</a></h4>The mREITs are back in favor after the Fed's QE&infin; hit interest margins in Q4. A widening yield curve helps, but managements weren't powerless either. Share buybacks below book and altered business plans - <a href=\"https://seekingalpha.com/currents/post/893101\" target=\"_blank\">Annaly's purchase</a> of CreXus for one, others upping exposure to non-agency RMBS another - are sitting well with investors. <font color=\"green\">Up 2.1%</font> today, <a href='https://seekingalpha.com/symbol/NLY' title='Annaly Capital Management, Inc.'>NLY</a> is trading above book for the first time in a long time.<div class=\"tiny-share-widget\" data-id=\"905391\" data-linked=\"The mREITs are back in favor after the Fed&#39;s QE&amp;infin; hit interest margins in Q4. A widening...\" data-tweet=\"$NLY $REM $REZ - The mREITs are back in favor after the Fed&#39;s QE&amp;infin; hit interest margins in Q4. A widening yield curve helps, but managements weren&#39;t powerless either. Share buybacks below book and altered business plans - Annaly&#39;s purchase of CreXu... https://seekingalpha.com/news/905391?source=tweet\" data-url=\"https://seekingalpha.com/news/905391\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905381\" data-ts=\"1363971929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMX\" target=\"_blank\">AMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905381\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After 14 hours of debate, Mexico&#39;s lower house has approved an amended version of a telecom...</a></h4><p>After 14 hours of debate, <a target=\"_blank\" href=\"http://www.reuters.com/article/2013/03/22/us-mexico-telecoms-vote-idUSBRE92L0RM20130322?feedType=RSS&amp;feedName=technologyNews\">Mexico's lower house has approved</a> an amended version of a <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/880411\">telecom reform bill</a> that seeks to create a new independent regulator and remove foreign investment limits on wireline carriers. Some details still need to be worked out, such as whether reciprocal foreign investment arrangements should be required of the home countries of investing firms. America Movil (<a href=\"https://seekingalpha.com/symbol/AMX\" title=\"America Movil SA de CV\">AMX</a> <font color=\"green\">+2.8%</font>) is rallying for the second day in a row. Grupo Televisa (<a href=\"https://seekingalpha.com/symbol/TV\" title=\"Grupo Televisa, S.A.\">TV</a> <font color=\"green\">+0.6%</font>) is up slightly.</p><div class=\"tiny-share-widget\" data-id=\"905381\" data-linked=\"After 14 hours of debate, Mexico&#39;s lower house has approved an amended version of a telecom...\" data-tweet=\"$AMX $AMX $TV - After 14 hours of debate, Mexico&#39;s lower house has approved an amended version of a telecom reform bill that seeks to create a new independent regulator and remove foreign investment limits on wireline carriers. Some details still need t... https://seekingalpha.com/news/905381?source=tweet\" data-url=\"https://seekingalpha.com/news/905381\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905371\" data-ts=\"1363971574\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAA\" target=\"_blank\">UAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905371\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Under Armour (UA +3.6%) trades higher with Nike&#39;s strong performance in North America helping to...</a></h4>Under Armour (<a href='https://seekingalpha.com/symbol/UA' title='Under Armour, Inc. Class C'>UA</a> <font color='green'>+3.6%</font>) trades higher with Nike's <a href=\"https://seekingalpha.com/currents/post/904851\" target=\"_blank\">strong performance</a> in North America helping to tip sentiment. Though most analysts think there is enough global demand for both sports apparel companies to thrive, the question on Under Armour is if it can match Nike's success on the margins front.<div class=\"tiny-share-widget\" data-id=\"905371\" data-linked=\"Under Armour (UA +3.6%) trades higher with Nike&#39;s strong performance in North America helping to...\" data-tweet=\"$UAA - Under Armour (UA +3.6%) trades higher with Nike&#39;s strong performance in North America helping to tip sentiment. Though most analysts think there is enough global demand for both sports apparel companies to thrive, the question on Under Armour is ... https://seekingalpha.com/news/905371?source=tweet\" data-url=\"https://seekingalpha.com/news/905371\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905361\" data-ts=\"1363971131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPK\" target=\"_blank\">GPK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905361\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Graphic Packaging (GPK -2.8%) slides after the company announced that selling stockholders have...</a></h4><p>Graphic Packaging (<a href=\"https://seekingalpha.com/symbol/GPK\" title=\"Graphic Packaging Holding Company\">GPK</a> <font color=\"red\">-2.8%</font>) slides after the company announced that selling stockholders have increased the size of its previously announced secondary offering from 25M shares to 28M shares and priced it at $7 per share.</p><div class=\"tiny-share-widget\" data-id=\"905361\" data-linked=\"Graphic Packaging (GPK -2.8%) slides after the company announced that selling stockholders have...\" data-tweet=\"$GPK - Graphic Packaging (GPK -2.8%) slides after the company announced that selling stockholders have increased the size of its previously announced secondary offering from 25M shares to 28M shares and priced it at $7 per share. https://seekingalpha.com/news/905361?source=tweet\" data-url=\"https://seekingalpha.com/news/905361\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905351\" data-ts=\"1363970578\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GT\" target=\"_blank\">GT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905351\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goodyear Tire (GT -1.6%) says it&#39;s begun construction on the first of a new generation of...</a></h4><p>Goodyear Tire (<a href=\"https://seekingalpha.com/symbol/GT\" title=\"Goodyear Tire &amp; Rubber Co.\">GT</a> <font color=\"red\">-1.6%</font>) says it's begun construction on the first of a new generation of airships to replace its fleet of blimps. The new Zeppelin LZ N07-101 airship, manufactured by Germany's ZLT Zeppelin Luftschifftechnik, will be assembled at <a href=\"https://seekingalpha.com/symbol/GT\" title=\"Goodyear Tire &amp; Rubber Co.\">GT</a>'s Wingfoot Lake Hangar near Akron, Ohio.</p><div class=\"tiny-share-widget\" data-id=\"905351\" data-linked=\"Goodyear Tire (GT -1.6%) says it&#39;s begun construction on the first of a new generation of...\" data-tweet=\"$GT - Goodyear Tire (GT -1.6%) says it&#39;s begun construction on the first of a new generation of airships to replace its fleet of blimps. The new Zeppelin LZ N07-101 airship, manufactured by Germany&#39;s ZLT Zeppelin Luftschifftechnik, will be assembled at ... https://seekingalpha.com/news/905351?source=tweet\" data-url=\"https://seekingalpha.com/news/905351\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905331\" data-ts=\"1363970388\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RTW\" target=\"_blank\">RTW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905331\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of New York &amp;amp; Co (NWY -10.3%) shoot lower after the retailer guides estimates for Q1...</a></h4>Shares of New York &amp; Co (NWY <font color='red'>-10.3%</font>) shoot lower after the retailer <a href=\"http://phx.corporate-ir.net/phoenix.zhtml?c=180241&amp;p=irol-newsArticle&amp;ID=1799026&amp;highlight=\" target=\"_blank\">guides</a> estimates for Q1 sales to below the consensus mark of analysts. The company says February sales have been weak and that for Q1 it now expects to see revenue dip in the low single-digit range (Y/Y).<div class=\"tiny-share-widget\" data-id=\"905331\" data-linked=\"Shares of New York &amp;amp; Co (NWY -10.3%) shoot lower after the retailer guides estimates for Q1...\" data-tweet=\"$RTW - Shares of New York &amp; Co (NWY -10.3%) shoot lower after the retailer guides estimates for Q1 sales to below the consensus mark of analysts. The company says February sales have been weak and that for Q1 it now expects to see revenue dip in the low... https://seekingalpha.com/news/905331?source=tweet\" data-url=\"https://seekingalpha.com/news/905331\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905241\" data-ts=\"1363969196\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANTH\" target=\"_blank\">ANTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905241\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anthera Pharmaceuticals (OTC:ANTH +2.4%) gains after announcing earlier today that data from its...</a></h4><p>Anthera Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ANTH\" title=\"Anthera Pharmaceuticals, Inc.\">OTC:ANTH</a> <font color=\"green\">+2.4%</font>) gains after announcing earlier today that data from its Phase 2b Pearl-SC study will be presented at the 10th International Congress on Systemic Lupus Erythematosus on April 20. The presentation will be in the form of an abstract entitled \"Blisibimod, an Emerging Subcutaneous Biologic Therapy for Patients with Active, Moderate-to-Severe Systemic Lupus Erythematosus.\"</p><div class=\"tiny-share-widget\" data-id=\"905241\" data-linked=\"Anthera Pharmaceuticals (OTC:ANTH +2.4%) gains after announcing earlier today that data from its...\" data-tweet=\"$ANTH - Anthera Pharmaceuticals (OTC:ANTH +2.4%) gains after announcing earlier today that data from its Phase 2b Pearl-SC study will be presented at the 10th International Congress on Systemic Lupus Erythematosus on April 20. The presentation will be i... https://seekingalpha.com/news/905241?source=tweet\" data-url=\"https://seekingalpha.com/news/905241\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905221\" data-ts=\"1363968685\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTNP\" target=\"_blank\">TTNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905221\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Titan Pharmaceuticals (TTNP +35%) rise dramatically after the company says the FDA...</a></h4><p>Shares of Titan Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/TTNP\" title=\"Titan Pharmaceuticals, Inc.\">TTNP</a> <font color=\"green\">+35%</font>) rise dramatically after the company says the FDA recommends approval for its opioid addiction treatment drug Probuphine. The terms of a <a href=\"http://www.titanpharm.com/press/2012/121217-press-rel-titan-partnering-update.htm\" target=\"_blank\">licensing agreement</a> announced last year indicate Titan will receive $50M from its commercialization partner Braeburn Pharmaceuticals upon FDA approval.<span class=\"Apple-converted-space\"> </span></p><div class=\"tiny-share-widget\" data-id=\"905221\" data-linked=\"Shares of Titan Pharmaceuticals (TTNP +35%) rise dramatically after the company says the FDA...\" data-tweet=\"$TTNP - Shares of Titan Pharmaceuticals (TTNP +35%) rise dramatically after the company says the FDA recommends approval for its opioid addiction treatment drug Probuphine. The terms of a licensing agreement announced last year indicate Titan will recei... https://seekingalpha.com/news/905221?source=tweet\" data-url=\"https://seekingalpha.com/news/905221\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905171\" data-ts=\"1363967361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVDL\" target=\"_blank\">AVDL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905171\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flamel Technologies (FLML +3.2%) says that a U.S. District Court has dismissed a class action...</a></h4><p>Flamel Technologies (FLML <font color=\"green\">+3.2%</font>) says that a U.S. District Court has dismissed a class action suit against the company, and its former CEO. The initial class action, filed in 2007, alleged that the company made false claims about Coreg CR, a medication commonly used to treat conditions related to the heart and blood vessels. In dismissing the case, the judge stated that there was no substantive fact, and no reasonable jury could possibly find in the lead plaintiff's favor.</p><div class=\"tiny-share-widget\" data-id=\"905171\" data-linked=\"Flamel Technologies (FLML +3.2%) says that a U.S. District Court has dismissed a class action...\" data-tweet=\"$AVDL - Flamel Technologies (FLML +3.2%) says that a U.S. District Court has dismissed a class action suit against the company, and its former CEO. The initial class action, filed in 2007, alleged that the company made false claims about Coreg CR, a med... https://seekingalpha.com/news/905171?source=tweet\" data-url=\"https://seekingalpha.com/news/905171\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905101\" data-ts=\"1363966316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIBX\" target=\"_blank\">TIBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905101\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&quot;Our issues are primarily execution-related,&quot; Tibco (TIBX -15.3%) CEO Vivek Ranadive asserts on...</a></h4><p>\"Our issues are primarily execution-related,\" Tibco (<a href=\"https://seekingalpha.com/symbol/TIBX\" title=\"TIBCO Software, Inc.\">TIBX</a> <font color=\"red\">-15.3%</font>) CEO Vivek Ranadive asserts on his company's <a href=\"https://seekingalpha.com/article/1294281-tibco-software-management-discusses-q1-2013-results-earnings-call-transcript?part=single\" target=\"_blank\">FQ1 call</a>. He suggests Tibco has \"weak leadership\" in the Americas and the U.K., and hints at a restructuring. Shares have been hit with 2 downgrades following a <a href=\"https://seekingalpha.com/currents/post/903411\" target=\"_blank\">revenue miss</a> and <a href=\"https://seekingalpha.com/currents/post/903731\" target=\"_blank\">light guidance</a>. An 8% Y/Y sales drop in the critical finance vertical and a decline in $1M+ deals offset 50% growth in telecom. Randadive argues Tibco's ability to process both business transactions and events through its middleware/analytics offerings is a key differentiator. <a href=\"https://seekingalpha.com/symbol/INFA\" title=\"Informatica Corporation\">INFA</a> <font color=\"red\">-5.6%</font> (<a href=\"https://seekingalpha.com/currents/post/904881\" target=\"_blank\">previous</a>). <a href=\"https://seekingalpha.com/symbol/QLIK\" title=\"Qlik Technologies Inc.\">QLIK</a> <font color=\"red\">-3.1%</font>. <a href=\"https://seekingalpha.com/symbol/MSTR\" title=\"MicroStrategy Incorporated\">MSTR</a> <font color=\"red\">-2.2%</font>.</p><div class=\"tiny-share-widget\" data-id=\"905101\" data-linked=\"&quot;Our issues are primarily execution-related,&quot; Tibco (TIBX -15.3%) CEO Vivek Ranadive asserts on...\" data-tweet=\"$TIBX $TIBX $INFA - &quot;Our issues are primarily execution-related,&quot; Tibco (TIBX -15.3%) CEO Vivek Ranadive asserts on his company&#39;s FQ1 call. He suggests Tibco has &quot;weak leadership&quot; in the Americas and the U.K., and hints at a restructuring. Shares have b... https://seekingalpha.com/news/905101?source=tweet\" data-url=\"https://seekingalpha.com/news/905101\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905091\" data-ts=\"1363965683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GENTY\" target=\"_blank\">GENTY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905091\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gentium SpA (GENT -5.3%) trades lower today - albeit up significantly from the 16% pounding it...</a></h4><p>Gentium SpA (GENT <font color=\"red\">-5.3%</font>) trades lower today - albeit up significantly from the <font color=\"red\">16%</font> pounding it took just prior to the open - after the company said the European Medicines Agency's Committee for Medicinal Products for Human Use rejected Defibrotide, its treatment for hepatic veno-occlusive disease. GENT will appeal the EMA's decision.</p><div class=\"tiny-share-widget\" data-id=\"905091\" data-linked=\"Gentium SpA (GENT -5.3%) trades lower today - albeit up significantly from the 16% pounding it...\" data-tweet=\"$GENTY - Gentium SpA (GENT -5.3%) trades lower today - albeit up significantly from the 16% pounding it took just prior to the open - after the company said the European Medicines Agency&#39;s Committee for Medicinal Products for Human Use rejected Defibrot... https://seekingalpha.com/news/905091?source=tweet\" data-url=\"https://seekingalpha.com/news/905091\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"905051\" data-ts=\"1363964997\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/905051\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Lululemon (LULU -3.5%) take another a leg down despite a spirited defense from...</a></h4><p>Shares of Lululemon (<a href=\"https://seekingalpha.com/symbol/LULU\" title=\"Lululemon Athletica Inc.\">LULU</a> <font color=\"red\">-3.5%</font>) take another a leg down despite a spirited <a href=\"https://twitter.com/PriceTarget/status/315089579097083904\" target=\"_blank\">defense</a> from Canaccord Genuity (reiterated buy, $87 PT). Concerns about manufacturing issues look like they could linger for a while and the retailer's CEO response during an earnings conference call on how to detect a problem with too-thin yoga pants didn't overwhelm investors. Christine Day on quality control: \"The only way that you can actually test for the issue is to put the pants on and bend over.\" (<a href=\"https://seekingalpha.com/article/1292561-lululemon-athletica-ceo-discusses-q4-2012-results-earnings-call-transcript\" target=\"_blank\">transcript</a>)</p><div class=\"tiny-share-widget\" data-id=\"905051\" data-linked=\"Shares of Lululemon (LULU -3.5%) take another a leg down despite a spirited defense from...\" data-tweet=\"$LULU - Shares of Lululemon (LULU -3.5%) take another a leg down despite a spirited defense from Canaccord Genuity (reiterated buy, $87 PT). Concerns about manufacturing issues look like they could linger for a while and the retailer&#39;s CEO response duri... https://seekingalpha.com/news/905051?source=tweet\" data-url=\"https://seekingalpha.com/news/905051\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904981\" data-ts=\"1363963537\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALIM\" target=\"_blank\">ALIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904981\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alimera Sciences (ALIM +5.2%) pops after the company reported a better-than-expected Q4 loss of...</a></h4><p>Alimera Sciences (<a href=\"https://seekingalpha.com/symbol/ALIM\" title=\"Alimera Sciences, Inc.\">ALIM</a> <font color=\"green\">+5.2%</font>) pops after the company reported a <a href=\"https://seekingalpha.com/market_currents/post/903261\" target=\"_blank\">better-than-expected Q4</a> loss of $0.17, which beat analyst estimates of a loss of $0.23 per share, and was narrower than the prior year's loss of $0.19. Looking forward, the company says it's about to begin the commercial launch of Iluvien, a treatment for diabetic macular edema, and expects to begin generating revenue in the second quarter of this year. Read more on earnings here: <a href=\"https://seekingalpha.com/article/1294121-alimera-sciences-management-discusses-q4-2012-results-earnings-call-transcript\" target=\"_blank\">Earnings Call Transcript</a>.</p><div class=\"tiny-share-widget\" data-id=\"904981\" data-linked=\"Alimera Sciences (ALIM +5.2%) pops after the company reported a better-than-expected Q4 loss of...\" data-tweet=\"$ALIM - Alimera Sciences (ALIM +5.2%) pops after the company reported a better-than-expected Q4 loss of $0.17, which beat analyst estimates of a loss of $0.23 per share, and was narrower than the prior year&#39;s loss of $0.19. Looking forward, the company ... https://seekingalpha.com/news/904981?source=tweet\" data-url=\"https://seekingalpha.com/news/904981\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904961\" data-ts=\"1363963209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGLE\" target=\"_blank\">EGLE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904961\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The runaway rally in dry bulk shipping stocks isn&#39;t knocking the socks off of Wells Fargo. The...</a></h4><p>The runaway rally in dry bulk shipping stocks <a href=\"http://www.streetinsider.com/Analyst+Comments/Rally+in+Dry+Bulk+Has+a+Hole+in+It%2C+Thinks+Analyst+%28GNK%29/8206052.html\" target=\"_blank\">isn't knocking the socks off</a> of Wells Fargo. The investment firm is quick to point out that multiple companies in the sector are likely to see bankruptcy or restructuring. Proceed with caution: <a href=\"https://seekingalpha.com/symbol/EGLE\" title=\"Eagle Bulk Shipping Inc.\">EGLE</a>, <a href=\"https://seekingalpha.com/symbol/GNK\" title=\"Genco Shipping &amp; Trading Ltd.\">GNK</a>, <a href=\"https://seekingalpha.com/symbol/DRYS\" title=\"DryShips Inc.\">DRYS</a>, <a href=\"https://seekingalpha.com/symbol/DSX\" title=\"Diana Shipping, Inc.\">DSX</a>, PRGN, <a href=\"https://seekingalpha.com/symbol/NEWL\" title=\"NewLead Holdings Ltd.\">NEWL</a>, FREE, <a href=\"https://seekingalpha.com/symbol/NM\" title=\"Navios Maritime Holdings Inc.\">NM</a>, <a href=\"https://seekingalpha.com/symbol/SBLK\" title=\"Star Bulk Carriers Corp.\">SBLK</a>, <a href=\"https://seekingalpha.com/symbol/ESEA\" title=\"Euroseas Ltd.\">ESEA</a>.</p><div class=\"tiny-share-widget\" data-id=\"904961\" data-linked=\"The runaway rally in dry bulk shipping stocks isn&#39;t knocking the socks off of Wells Fargo. The...\" data-tweet=\"$EGLE $EGLE $GNK - The runaway rally in dry bulk shipping stocks isn&#39;t knocking the socks off of Wells Fargo. The investment firm is quick to point out that multiple companies in the sector are likely to see bankruptcy or restructuring. Proceed with cau... https://seekingalpha.com/news/904961?source=tweet\" data-url=\"https://seekingalpha.com/news/904961\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904911\" data-ts=\"1363962706\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANAC\" target=\"_blank\">ANAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904911\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Anacor Pharmaceuticals (ANAC +35%) rocket higher again today, adding to yesterday&#39;s...</a></h4><p>Shares of Anacor Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ANAC\" title=\"Anacor Pharmaceuticals, Inc.\">ANAC</a> <font color=\"green\">+35%</font>) rocket higher again today, adding to yesterday's <font color=\"green\">+26%</font> gain after the company announced <a href=\"https://seekingalpha.com/market_currents/post/903251\" target=\"_blank\">positive results</a> from a Phase 2 dose-ranging trial of its topical ointment, AN2728. The company said lesions treated with AN2728 achieved a 71% improvement from baseline in their Atopic Dermatitis Severity Index score, with 66% of lesions achieving total or partial clearance. The stock is now fast approach a 52-week high not seen since October of last year.</p><div class=\"tiny-share-widget\" data-id=\"904911\" data-linked=\"Shares of Anacor Pharmaceuticals (ANAC +35%) rocket higher again today, adding to yesterday&#39;s...\" data-tweet=\"$ANAC - Shares of Anacor Pharmaceuticals (ANAC +35%) rocket higher again today, adding to yesterday&#39;s +26% gain after the company announced positive results from a Phase 2 dose-ranging trial of its topical ointment, AN2728. The company said lesions trea... https://seekingalpha.com/news/904911?source=tweet\" data-url=\"https://seekingalpha.com/news/904911\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904901\" data-ts=\"1363962657\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRIN\" target=\"_blank\">MRIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904901\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marin Software&#39;s (NASDAQ:MRIN) IPO is as good as promised. After pricing its 7.5M-share offering...</a></h4><p>Marin Software's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MRIN\" title=\"Marin Software\">MRIN</a>) IPO is as good as <a href=\"https://seekingalpha.com/currents/post/903201\" target=\"_blank\">promised</a>. After pricing its 7.5M-share offering at $14 (above a range of $11-$13), shares opened at $19 and are currently at $17.90, <font color=\"green\">up 27.9%</font>. That gives the online ad campaign software firm a market cap of $553M, or 9.3x 2012 sales. (<a href=\"http://www.sec.gov/Archives/edgar/data/1389002/000119312513099614/d450382ds1a.htm\" target=\"_blank\">S-1</a>) (<a href=\"https://seekingalpha.com/currents/post/885961\" target=\"_blank\">previous</a>)</p><div class=\"tiny-share-widget\" data-id=\"904901\" data-linked=\"Marin Software&#39;s (NASDAQ:MRIN) IPO is as good as promised. After pricing its 7.5M-share offering...\" data-tweet=\"$MRIN - Marin Software&#39;s (NASDAQ:MRIN) IPO is as good as promised. After pricing its 7.5M-share offering at $14 (above a range of $11-$13), shares opened at $19 and are currently at $17.90, up 27.9%. That gives the online ad campaign software firm a mar... https://seekingalpha.com/news/904901?source=tweet\" data-url=\"https://seekingalpha.com/news/904901\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904871\" data-ts=\"1363962000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904871\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron&#39;s (MU +10.5%) FQ2 beat, partly driven by 8% Q/Q NAND flash sales growth, provides a lift...</a></h4><p>Micron's (<a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a> <font color=\"green\">+10.5%</font>) FQ2 beat, partly driven by 8% Q/Q <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/903401\">NAND flash sales growth</a>, provides a lift to SanDisk (SNDK <font color=\"green\">+2%</font>). Micron stated on its <a target=\"_blank\" href=\"https://seekingalpha.com/article/1294301-micron-technology-s-ceo-discusses-f2q-2013-results-earnings-call-transcript\">earnings call</a> it sees \"a favorable supply and demand balance\" for NAND, thanks to strong SSD/mobile device demand and slowing manufacturing process shifts. Micron's trade NAND ASP was \"relatively flat\" in FQ2, and is estimated to be down mid-single-digits thus far in FQ3. Micron also forecasts DRAM industry capacity will fall in 2013 and 2014, and suggests it will shift some of its DRAM capacity to NAND. (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/904341\">previous</a>)</p><div class=\"tiny-share-widget\" data-id=\"904871\" data-linked=\"Micron&#39;s (MU +10.5%) FQ2 beat, partly driven by 8% Q/Q NAND flash sales growth, provides a lift...\" data-tweet=\"$MU $MU $WDC - Micron&#39;s (MU +10.5%) FQ2 beat, partly driven by 8% Q/Q NAND flash sales growth, provides a lift to SanDisk (SNDK +2%). Micron stated on its earnings call it sees &quot;a favorable supply and demand balance&quot; for NAND, thanks to strong SSD/mobil... https://seekingalpha.com/news/904871?source=tweet\" data-url=\"https://seekingalpha.com/news/904871\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904851\" data-ts=\"1363961797\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904851\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nike&#39;s (NKE +10.9%) broad sales gains in North America and e-commerce channels during Q4 were...</a></h4><p>Nike's (<a href=\"https://seekingalpha.com/symbol/NKE\" title=\"Nike Inc.\">NKE</a> <font color=\"green\">+10.9%</font>) <a href=\"https://seekingalpha.com/currents/post/903591\" target=\"_blank\">broad sales gains</a> in North America and e-commerce channels during Q4 were impressive enough to help drive shares to 52-week highs, but Morningstar <a href=\"http://www.nytimes.com/2013/03/22/business/nike-profit-rises-despite-weak-china-sales.html\" target=\"_blank\">warns</a> that long-term sales growth needs to be derived from China and other emerging markets. Revenue in China fell 9% to $635M as a couple of misfires on product strategy dealt a blow. What to watch: If <a href=\"http://app.hedgeye.com/unlocked_content/27435-nike-three-for-three-in-q3\" target=\"_blank\">gross margins</a> continue to impress and the company can execute in China and Japan while keeping its momentum going in North America - even more upside could be in store.</p><div class=\"tiny-share-widget\" data-id=\"904851\" data-linked=\"Nike&#39;s (NKE +10.9%) broad sales gains in North America and e-commerce channels during Q4 were...\" data-tweet=\"$NKE - Nike&#39;s (NKE +10.9%) broad sales gains in North America and e-commerce channels during Q4 were impressive enough to help drive shares to 52-week highs, but Morningstar warns that long-term sales growth needs to be derived from China and other emer... https://seekingalpha.com/news/904851?source=tweet\" data-url=\"https://seekingalpha.com/news/904851\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904771\" data-ts=\"1363960446\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZIOP\" target=\"_blank\">ZIOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904771\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ziopharm Oncology (ZIOP -5.8%) opens down big after Adam Feurstein reports an oft-correct source...</a></h4>Ziopharm Oncology (<a href='https://seekingalpha.com/symbol/ZIOP' title='ZIOPHARM Oncology, Inc.'>ZIOP</a> <font color=\"red\">-5.8%</font>) opens down big after Adam Feurstein reports an oft-correct source <a href=\"http://www.thestreet.com/story/11877173/1/why-this-fund-manager-is-short-ziopharm.html\" target=\"_blank\">has shorted the stock</a> ahead of what he/she thinks will be the failure of next week's results of the palifosfamide sarcoma study.<div class=\"tiny-share-widget\" data-id=\"904771\" data-linked=\"Ziopharm Oncology (ZIOP -5.8%) opens down big after Adam Feurstein reports an oft-correct source...\" data-tweet=\"$ZIOP - Ziopharm Oncology (ZIOP -5.8%) opens down big after Adam Feurstein reports an oft-correct source has shorted the stock ahead of what he/she thinks will be the failure of next week&#39;s results of the palifosfamide sarcoma study. https://seekingalpha.com/news/904771?source=tweet\" data-url=\"https://seekingalpha.com/news/904771\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904751\" data-ts=\"1363960182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPM\" target=\"_blank\">WPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904751\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Silver Wheaton (SLW +2.1%) shoots higher at the open after last night&#39;s Q4 report said earnings...</a></h4>Silver Wheaton (SLW <font color=\"green\">+2.1%</font>) shoots higher at the open after last night's <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/904001\">Q4 report</a> said earnings hit a record $0.50/share vs. $0.41 a year earlier and revenue also set a record at $287M. Attributable silver equivalent output rose 22% to 8.5M oz. Average cash costs rose to $4.70 per silver equivalent oz. from $4.06 a year ago.<div class=\"tiny-share-widget\" data-id=\"904751\" data-linked=\"Silver Wheaton (SLW +2.1%) shoots higher at the open after last night&#39;s Q4 report said earnings...\" data-tweet=\"$WPM $SLVP $SIL - Silver Wheaton (SLW +2.1%) shoots higher at the open after last night&#39;s Q4 report said earnings hit a record $0.50/share vs. $0.41 a year earlier and revenue also set a record at $287M. Attributable silver equivalent output rose 22% to... https://seekingalpha.com/news/904751?source=tweet\" data-url=\"https://seekingalpha.com/news/904751\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904741\" data-ts=\"1363959818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDLZ\" target=\"_blank\">MDLZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904741\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mondelez (MDLZ +2.9%) trades higher with a Nelson Peltz-premium getting baked into shares on the...</a></h4><p>Mondelez (<a href=\"https://seekingalpha.com/symbol/MDLZ\" title=\"Mondelēz International, Inc.\">MDLZ</a> <font color=\"green\">+2.9%</font>) trades higher with a <a href=\"https://seekingalpha.com/currents/post/903881\" target=\"_blank\">Nelson Peltz-premium</a> getting baked into shares on the prospect that the activist investor could push for major changes at the company - possibly even a merger with PepsiCo. JPMorgan analyst Ken Goldman is <a href=\"http://us4.campaign-archive2.com/?u=3870e293ae35fe568ab831f5d&amp;id=be06b2d44d\" target=\"_blank\">raining on</a> the PEP-MDLZ speculation parade a bit, saying the companies wouldn't blend together neatly and that a deal could raise anti-trust issues.</p><div class=\"tiny-share-widget\" data-id=\"904741\" data-linked=\"Mondelez (MDLZ +2.9%) trades higher with a Nelson Peltz-premium getting baked into shares on the...\" data-tweet=\"$MDLZ - Mondelez (MDLZ +2.9%) trades higher with a Nelson Peltz-premium getting baked into shares on the prospect that the activist investor could push for major changes at the company - possibly even a merger with PepsiCo. JPMorgan analyst Ken Goldman ... https://seekingalpha.com/news/904741?source=tweet\" data-url=\"https://seekingalpha.com/news/904741\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904711\" data-ts=\"1363959332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/R\" target=\"_blank\">R</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904711\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Raymond James upgrades Ryder System (R +2.9%) to Strong Buy with a $74 price target. The shares...</a></h4><p>Raymond James <a href=\"http://www.cnbc.com/id/100581806\" target=\"_blank\">upgrades</a> Ryder System (<a href=\"https://seekingalpha.com/symbol/R\" title=\"Ryder System, Inc.\">R</a> <font color=\"green\">+2.9%</font>) to Strong Buy with a $74 price target. The shares are trading higher on the news.<span class=\"Apple-converted-space\"> </span></p><div class=\"tiny-share-widget\" data-id=\"904711\" data-linked=\"Raymond James upgrades Ryder System (R +2.9%) to Strong Buy with a $74 price target. The shares...\" data-tweet=\"$R - Raymond James upgrades Ryder System (R +2.9%) to Strong Buy with a $74 price target. The shares are trading higher on the news.  https://seekingalpha.com/news/904711?source=tweet\" data-url=\"https://seekingalpha.com/news/904711\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904671\" data-ts=\"1363958993\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HALO\" target=\"_blank\">HALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904671\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halozyme Therapeutics (NASDAQ:HALO) +18.6% premarket after the European Medicines Agency...</a></h4><p>Halozyme Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HALO\" title=\"Halozyme Therapeutics, Inc.\">HALO</a>) <font color=\"green\">+18.6%</font> premarket after the European Medicines Agency approves partner Baxter (NYSE:<a href=\"https://seekingalpha.com/symbol/BAX\" title=\"Baxter International Inc\">BAX</a>) for the use of HALO's HyQvia  as replacement therapy for adult patients with primary and secondary immunodeficiencies. Upon receiving marketing authorization from the EC, BAX plans to launch HyQvia in some European countries later this year.</p><div class=\"tiny-share-widget\" data-id=\"904671\" data-linked=\"Halozyme Therapeutics (NASDAQ:HALO) +18.6% premarket after the European Medicines Agency...\" data-tweet=\"$HALO $HALO $BAX - Halozyme Therapeutics (NASDAQ:HALO) +18.6% premarket after the European Medicines Agency approves partner Baxter (NYSE:BAX) for the use of HALO&#39;s HyQvia as replacement therapy for adult patients with primary and secondary immunodefici... https://seekingalpha.com/news/904671?source=tweet\" data-url=\"https://seekingalpha.com/news/904671\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904561\" data-ts=\"1363957825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HALO\" target=\"_blank\">HALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904561\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: HALO +23%. ANAC +18%. MU +9%. OTC:AFFY +8%. NKE +8%.Losers: TIBX -16%. ABR...</a></h4><b>Premarket gainers:</b> <a href=\"https://seekingalpha.com/symbol/HALO\" title=\"Halozyme Therapeutics, Inc.\">HALO</a> <font color=\"green\">+23%</font>. <a href=\"https://seekingalpha.com/symbol/ANAC\" title=\"Anacor Pharmaceuticals, Inc.\">ANAC</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/AFFY\" title=\"Affymax, Inc.\">OTC:AFFY</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/NKE\" title=\"Nike Inc.\">NKE</a> <font color=\"green\">+8%</font>.<br><b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/TIBX\" title=\"TIBCO Software, Inc.\">TIBX</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/ABR\" title=\"Arbor Realty Trust, Inc.\">ABR</a> <font color=\"red\">-6%</font>. <a href=\"https://seekingalpha.com/symbol/ZIOP\" title=\"ZIOPHARM Oncology, Inc.\">ZIOP</a> <font color=\"red\">-5%</font>.<div class=\"tiny-share-widget\" data-id=\"904561\" data-linked=\"Premarket gainers: HALO +23%. ANAC +18%. MU +9%. OTC:AFFY +8%. NKE +8%.Losers: TIBX -16%. ABR...\" data-tweet=\"$HALO $HALO $ANAC - Premarket gainers: HALO +23%. ANAC +18%. MU +9%. OTC:AFFY +8%. NKE +8%.Losers: TIBX -16%. ABR -6%. ZIOP -5%. https://seekingalpha.com/news/904561?source=tweet\" data-url=\"https://seekingalpha.com/news/904561\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904361\" data-ts=\"1363955401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEP\" target=\"_blank\">PEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904361\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PepsiCo (NYSE:PEP) unveils a new shape for 20-ounce bottles of Pepsi products as part of a...</a></h4><p>PepsiCo (NYSE:<a href=\"https://seekingalpha.com/symbol/PEP\" title=\"PepsiCo Inc.\">PEP</a>) <a href=\"http://www.cnbc.com/id/100581600\" target=\"_blank\">unveils</a> a new shape for 20-ounce bottles of Pepsi products as part of a broader plan to update marketing and packaging materials for the brand. The company's overall beverage volume in the North America declined 4% last year and it has been losing market share in the Coke vs. Pepsi battle. PEP <font color=\"green\">+1.8%</font> premarket with buzz picking up on what Trian Fund Management's <a href=\"https://seekingalpha.com/currents/post/903881\" target=\"_blank\">new investment</a> might portend.</p><div class=\"tiny-share-widget\" data-id=\"904361\" data-linked=\"PepsiCo (NYSE:PEP) unveils a new shape for 20-ounce bottles of Pepsi products as part of a...\" data-tweet=\"$PEP - PepsiCo (NYSE:PEP) unveils a new shape for 20-ounce bottles of Pepsi products as part of a broader plan to update marketing and packaging materials for the brand. The company&#39;s overall beverage volume in the North America declined 4% last year an... https://seekingalpha.com/news/904361?source=tweet\" data-url=\"https://seekingalpha.com/news/904361\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904341\" data-ts=\"1363954736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904341\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron (NASDAQ:MU) now higher by 7.7% post-earnings as Jefferies raises its price target to a...</a></h4><p>Micron (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a>) now <font color=\"green\">higher by 7.7%</font> post-<a href=\"https://seekingalpha.com/currents/post/903281\" target=\"_blank\">earnings</a> as Jefferies raises its price target to a Street-high $15 from $10, <a href=\"https://twitter.com/thenotablecalls/status/315072013767147521\" target=\"_blank\">while bumping</a> its 2013 and 2014 EPS estimates to $0.48 (from -$0.20) and $2.57 (from $0.76), respectively. \"We believe there is upside to our Street-high estimates.\" Credit Suisse <a href=\"https://twitter.com/thenotablecalls/status/315071874839224320\" target=\"_blank\">raises its PT </a>to $14 from $8, highlighting extremely favorable supply dynamics.</p><div class=\"tiny-share-widget\" data-id=\"904341\" data-linked=\"Micron (NASDAQ:MU) now higher by 7.7% post-earnings as Jefferies raises its price target to a...\" data-tweet=\"$MU - Micron (NASDAQ:MU) now higher by 7.7% post-earnings as Jefferies raises its price target to a Street-high $15 from $10, while bumping its 2013 and 2014 EPS estimates to $0.48 (from -$0.20) and $2.57 (from $0.76), respectively. &quot;We believe there is... https://seekingalpha.com/news/904341?source=tweet\" data-url=\"https://seekingalpha.com/news/904341\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904331\" data-ts=\"1363954687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MFRM\" target=\"_blank\">MFRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904331\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel Nicolaus upgrades Mattress Firm (NASDAQ:MFRM) to a Buy rating from Hold with a $37 price...</a></h4><p>Stifel Nicolaus <a href=\"https://twitter.com/Briefingcom/status/315071179243257864\" target=\"_blank\">upgrades</a> Mattress Firm (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MFRM\" title=\"Mattress Firm Holding Corp.\">MFRM</a>) to a Buy rating from Hold with a $37 price target. Shares of MFRM are <font color=\"green\">1.7% higher</font> premarket while the mattress sector (<a href=\"https://seekingalpha.com/symbol/TPX\" title=\"Tempur Sealy International Inc.\">TPX</a>, ZZ, SCSS) is on watch for a sympathy rally.</p><div class=\"tiny-share-widget\" data-id=\"904331\" data-linked=\"Stifel Nicolaus upgrades Mattress Firm (NASDAQ:MFRM) to a Buy rating from Hold with a $37 price...\" data-tweet=\"$MFRM $MFRM $TPX - Stifel Nicolaus upgrades Mattress Firm (NASDAQ:MFRM) to a Buy rating from Hold with a $37 price target. Shares of MFRM are 1.7% higher premarket while the mattress sector (TPX, ZZ, SCSS) is on watch for a sympathy rally. https://seekingalpha.com/news/904331?source=tweet\" data-url=\"https://seekingalpha.com/news/904331\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904291\" data-ts=\"1363954343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904291\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Execs with Nike (NYSE:NKE) highlighted the &quot;huge&quot; consumer demand for the company&#39;s expanded...</a></h4><p>Execs with Nike (NYSE:<a href=\"https://seekingalpha.com/symbol/NKE\" title=\"Nike Inc.\">NKE</a>) highlighted the \"huge\" consumer demand for the company's expanded launch of the Flyknit brand of running shoes during the firm's earnings conference call. The next phase: Nike plans to bring capacity up to speed with demand and sees leveraging Flyknit across other categories. NKE <font color=\"green\">+7.8%</font> premarket. (<a href=\"https://seekingalpha.com/article/1294261-nike-s-ceo-discusses-f3q-2013-results-earnings-call-transcript\" target=\"_blank\">transcript</a>)</p><div class=\"tiny-share-widget\" data-id=\"904291\" data-linked=\"Execs with Nike (NYSE:NKE) highlighted the &quot;huge&quot; consumer demand for the company&#39;s expanded...\" data-tweet=\"$NKE - Execs with Nike (NYSE:NKE) highlighted the &quot;huge&quot; consumer demand for the company&#39;s expanded launch of the Flyknit brand of running shoes during the firm&#39;s earnings conference call. The next phase: Nike plans to bring capacity up to speed with de... https://seekingalpha.com/news/904291?source=tweet\" data-url=\"https://seekingalpha.com/news/904291\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904271\" data-ts=\"1363953843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904271\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Nikkei dives 2.4% and the yen (FXY) strengthens 0.4% as new BOJ Governor Kuroda&#39;s...</a></h4><p>The Nikkei <font color=\"red\">dives 2.4%</font>  and the yen (<a href=\"https://seekingalpha.com/symbol/fxy\" title=\"CurrencyShares Japanese Yen Trust ETF\">FXY</a>) <font color=\"green\">strengthens 0.4%</font>  as new BOJ Governor Kuroda's ex-colleagues <a href=\"http://www.bloomberg.com/news/2013-03-21/kuroda-confident-in-getting-2-inflation-as-boj-readies-stimulus.html\" target=\"_blank\">express doubt </a>about his vows to hit a 2% inflation target. Included was the man formerly known as Mr. Yen for his ability to divine (and drive) the currency's moves - Eisuke Sakakibara - saying the inflation rate \"will never reach 2% ... the deflation is structural.\" <a href=\"https://seekingalpha.com/symbol/ewj\" title=\"iShares MSCI Japan Index ETF\">EWJ</a> <font color=\"red\">-0.6%</font> , <a href=\"https://seekingalpha.com/symbol/dxj\" title=\"WisdomTree Japan Hedged Equity ETF\">DXJ</a> <font color=\"red\">-0.4%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"904271\" data-linked=\"The Nikkei dives 2.4% and the yen (FXY) strengthens 0.4% as new BOJ Governor Kuroda&#39;s...\" data-tweet=\"$FXY $EWJ $DXJ - The Nikkei dives 2.4% and the yen (FXY) strengthens 0.4% as new BOJ Governor Kuroda&#39;s ex-colleagues express doubt about his vows to hit a 2% inflation target. Included was the man formerly known as Mr. Yen for his ability to divine (and... https://seekingalpha.com/news/904271?source=tweet\" data-url=\"https://seekingalpha.com/news/904271\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904231\" data-ts=\"1363952852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BP\" target=\"_blank\">BP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904231\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After nearly three years of hell since the Deepwater Horizon disaster whacked nearly 30% from...</a></h4><p>After nearly three years of hell since the Deepwater Horizon disaster whacked nearly 30% from the value of their holdings, <a href=\"https://seekingalpha.com/symbol/BP\" title=\"BP p.l.c.\">BP</a> shareholders finally get something back via the <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/903901\">$8B share buyback</a>. But the buyback will only serve to <a target=\"_blank\" href=\"http://www.bp.com/genericarticle.do?categoryId=2012968&amp;contentId=7085356\">offset the EPS dilution</a> now that BP <a href=\"https://seekingalpha.com/currents/post/902261\" target=\"_blank\">will no longer receive profits</a> from its Russian cash cow; TNK-BP once generated ~30% of BP\u2019s output and ~25% of its net profit. Shares <font color=\"green\">+3.1%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"904231\" data-linked=\"After nearly three years of hell since the Deepwater Horizon disaster whacked nearly 30% from...\" data-tweet=\"$BP - After nearly three years of hell since the Deepwater Horizon disaster whacked nearly 30% from the value of their holdings, BP shareholders finally get something back via the $8B share buyback. But the buyback will only serve to offset the EPS dilu... https://seekingalpha.com/news/904231?source=tweet\" data-url=\"https://seekingalpha.com/news/904231\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"904201\" data-ts=\"1363952140\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIF\" target=\"_blank\">TIF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/904201\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Tiffany (NYSE:TIF) move 3.1% higher premarket as investors look at the glass half-full...</a></h4><p>Shares of Tiffany (NYSE:<a href=\"https://seekingalpha.com/symbol/TIF\" title=\"Tiffany &amp; Co.\">TIF</a>) move <font color=\"green\">3.1% higher</font> premarket as investors look at the glass half-full on the company's <a href=\"https://seekingalpha.com/currents/post/904141\" target=\"_blank\">mixed report</a> for Q4. Retail analyst Stacey Widlitz acknowledges the retailer's improvement in Japan and stable guidance, but <a href=\"https://twitter.com/StaceyRetail/status/315060936966807553\" target=\"_blank\">notes</a> the two-year same-store sales comparisons look weak.</p><div class=\"tiny-share-widget\" data-id=\"904201\" data-linked=\"Shares of Tiffany (NYSE:TIF) move 3.1% higher premarket as investors look at the glass half-full...\" data-tweet=\"$TIF - Shares of Tiffany (NYSE:TIF) move 3.1% higher premarket as investors look at the glass half-full on the company&#39;s mixed report for Q4. Retail analyst Stacey Widlitz acknowledges the retailer&#39;s improvement in Japan and stable guidance, but notes t... https://seekingalpha.com/news/904201?source=tweet\" data-url=\"https://seekingalpha.com/news/904201\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"903961\" data-ts=\"1363943421\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/903961\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Germany&#39;s Ifo Index of business confidence unexpectedly drops to 106.7 this month from 107.4 in...</a></h4><p>Germany's Ifo Index of business confidence unexpectedly drops to 106.7 this month from 107.4 in February and vs consensus of 107.6. Current assessment 109.9 vs 110.2 and 110.4. Expectations 103.6 vs 104.6 and 104.9. The Dax immediately dives but quickly recovers to its previous level of <font color=\"red\">-0.5%</font>, while the euro also slides and is flat.</p><div class=\"tiny-share-widget\" data-id=\"903961\" data-linked=\"Germany&#39;s Ifo Index of business confidence unexpectedly drops to 106.7 this month from 107.4 in...\" data-tweet=\"$BUND $EWG - Germany&#39;s Ifo Index of business confidence unexpectedly drops to 106.7 this month from 107.4 in February and vs consensus of 107.6. Current assessment 109.9 vs 110.2 and 110.4. Expectations 103.6 vs 104.6 and 104.9. The Dax immediately dive... https://seekingalpha.com/news/903961?source=tweet\" data-url=\"https://seekingalpha.com/news/903961\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"903951\" data-ts=\"1363942899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/903951\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asian and European shares are mostly lower as the crisis in Cyprus heads for what could be the...</a></h4><p>Asian and <a href=\"http://www.bloomberg.com/news/2013-03-22/europe-stock-index-futures-fall-as-cyprus-debates-bailout.html\" target=\"_blank\">European shares</a> are mostly lower as the <a href=\"https://seekingalpha.com/currents/search?query=cyprus\" target=\"_blank\">crisis in Cyprus</a> heads for what could be the endgame on Monday, with an exit from eurozone not an impossibility. Japanese fell<a href=\"http://www.marketwatch.com/story/japanese-stocks-fall-sharply-in-weak-asia-2013-03-21\" target=\"_blank\"> especially sharply</a> after new BOJ governor Haruhiko Kuroda yesterday offered no new details about how he's going to print his country out of deflation. Japan <font color=\"red\">-2.4%</font>, Hong Kong <font color=\"red\">-0.5%</font>, China <font color=\"green\">+0.2%</font>, India <font color=\"red\">-0.3%</font>. EU Stoxx 50 <font color=\"red\">-0.6%</font>, London <font color=\"red\">-0.2%</font>, Paris <font color=\"red\">-0.4%</font>, Frankfurt <font color=\"red\">-0.5%</font>, Milan <font color=\"red\">-0.4%</font>, Madrid <font color=\"red\">-0.9%</font>.</p><div class=\"tiny-share-widget\" data-id=\"903951\" data-linked=\"Asian and European shares are mostly lower as the crisis in Cyprus heads for what could be the...\" data-tweet=\"Asian and European shares are mostly lower as the crisis in Cyprus heads for what could be the endgame on Monday, with an exit from eurozone not an impossibility. Japanese fell especially sharply after new BOJ governor Haruhiko Kuroda yesterday offered ... https://seekingalpha.com/news/903951?source=tweet\" data-url=\"https://seekingalpha.com/news/903951\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:01 AM </div></div></li>","count":50,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}